Literature DB >> 15247847

Rehabilitative management of patients with disorders of consciousness: grand rounds.

Joseph T Giacino1, Charlotte T Trott.   

Abstract

BACKGROUND: There are no standards of care to guide the selection of rehabilitation assessment and treatment procedures for patients with disorders of consciousness. Recently, consensus-based recommendations for management of patients in the vegetative and minimally conscious states have been developed and disseminated in neurology and neurorehabilitation. This is an important first step toward achieving evidence-based guidelines of care.
OBJECTIVE: Using a "Grand Rounds" format, we illustrate the application of consensus-based diagnostic, prognostic, and treatment recommendations in a patient who sustained severe traumatic brain injury with prolonged alteration in consciousness. After discussing the salient features of the case, we summarize the basic tenets of clinical care for this population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247847     DOI: 10.1097/00001199-200405000-00006

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  10 in total

1.  Quantitative assessment of visual behavior in disorders of consciousness.

Authors:  L Trojano; P Moretta; V Loreto; A Cozzolino; L Santoro; A Estraneo
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

Review 2.  Techniques of cognitive rehabilitation in patients with disorders of consciousness: a systematic review.

Authors:  Elena La Gattuta; Francesco Corallo; Viviana Lo Buono; Simona De Salvo; Fabrizia Caminiti; Carmela Rifici; Antonella Alagna; Francesca Arcadi; Alessia Bramanti; Silvia Marino
Journal:  Neurol Sci       Date:  2018-01-05       Impact factor: 3.307

3.  Prediction of Consciousness Recovery in Coma after Traumatic Brain Injury by Disorder of Consciousness Scale (DOCS).

Authors:  Somaye Kavusipur; Zahra Rojhani Shirazi; Zahra Ardekani; Soqra Omidi
Journal:  Bull Emerg Trauma       Date:  2013-04

4.  Microswitch technology and contingent stimulation to promote adaptive engagement in persons with minimally conscious state: a case evaluation.

Authors:  Giulio E Lancioni; Nirbhay N Singh; Mark F O'Reilly; Jeff Sigafoos; Maria Teresa Amenduni; Jorge Navarro; Francesca Buonocunto; Tommaso Scarabino; Marta Olivetti Belardinelli
Journal:  Cogn Process       Date:  2011-12-01

Review 5.  Disorders of consciousness after acquired brain injury: the state of the science.

Authors:  Joseph T Giacino; Joseph J Fins; Steven Laureys; Nicholas D Schiff
Journal:  Nat Rev Neurol       Date:  2014-01-28       Impact factor: 42.937

6.  Learning as a possible sign of non-reflective consciousness in persons with a diagnosis of vegetative state and pervasive motor impairment.

Authors:  Andrea Bosco; Giulio E Lancioni; Marta Olivetti Belardinelli; Nirbhay N Singh; Mark F O'Reilly; Jeff Sigafoos
Journal:  Cogn Process       Date:  2009-08-20

7.  Treatment of post-traumatic cognitive impairments.

Authors:  Hal S Wortzel; David B Arciniegas
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

Review 8.  How should functional imaging of patients with disorders of consciousness contribute to their clinical rehabilitation needs?

Authors:  Steven Laureys; Joseph T Giacino; Nicholas D Schiff; Manuel Schabus; Adrian M Owen
Journal:  Curr Opin Neurol       Date:  2006-12       Impact factor: 5.710

9.  Right median nerve electrical stimulation for acute traumatic coma (the Asia Coma Electrical Stimulation trial): study protocol for a randomised controlled trial.

Authors:  Xiang Wu; Chao Zhang; Junfeng Feng; Qing Mao; Guoyi Gao; Jiyao Jiang
Journal:  Trials       Date:  2017-07-10       Impact factor: 2.279

10.  Effects of transcranial direct current stimulation on patients with disorders of consciousness after traumatic brain injury: study protocol for a randomized, double-blind controlled trial.

Authors:  Shilin Li; Xiangli Dong; Weiming Sun; Na Zhao; Guohua Yu; Lang Shuai
Journal:  Trials       Date:  2019-10-17       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.